• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low prevalence of post-COVID-19 syndrome in patients with asthma.

作者信息

Garcia-Pachon Eduardo, Grau-Delgado Justo, Soler-Sempere Maria J, Zamora-Molina Lucia, Baeza-Martinez Carlos, Ruiz-Alcaraz Sandra, Padilla-Navas Isabel

机构信息

Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.

Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.

出版信息

J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.023. Epub 2021 Apr 2.

DOI:10.1016/j.jinf.2021.03.023
PMID:33819552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8017946/
Abstract
摘要

相似文献

1
Low prevalence of post-COVID-19 syndrome in patients with asthma.哮喘患者中新冠后综合征的低患病率。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.023. Epub 2021 Apr 2.
2
Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.西班牙马德里新冠肺炎住院患者中合并2型疾病的哮喘患者的患病率、特征及结局
J Investig Allergol Clin Immunol. 2020;30(5):382-384. doi: 10.18176/jiaci.0627. Epub 2020 Jun 18.
3
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.为何 COVID-19 患者的哮喘发病率较低，这证明了将 EDTA 溶液重新用于预防和治疗 COVID-19 疾病是合理的。
Med Hypotheses. 2020 Nov;144:110027. doi: 10.1016/j.mehy.2020.110027. Epub 2020 Jun 26.
4
Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.哮喘患者中新冠后长期症状的患病率相似：一项病例对照研究。
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.04.034. Epub 2021 May 3.
5
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究：SARS-CoV-2逆转录实时聚合酶链反应（rtRT-PCR）检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
6
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study.因严重急性呼吸综合征冠状病毒2型肺炎住院的哮喘患者的临床病程及结局：一项单中心回顾性研究。
Ann Allergy Asthma Immunol. 2020 Dec;125(6):707-709. doi: 10.1016/j.anai.2020.07.029. Epub 2020 Aug 1.
7
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
8
Impact of COVID-19 on patients with asthma.新冠病毒病对哮喘患者的影响。
Int J Tuberc Lung Dis. 2020 Nov 1;24(11):1217-1219. doi: 10.5588/ijtld.20.0608.
9
The association between COVID-19 and asthma: A systematic review and meta-analysis.2019冠状病毒病与哮喘之间的关联：一项系统评价和荟萃分析。
Clin Exp Allergy. 2020 Nov;50(11):1274-1277. doi: 10.1111/cea.13733. Epub 2020 Sep 24.
10
Severe asthma and COVID-19: lessons from the first wave.严重哮喘与 COVID-19：来自第一波疫情的教训。
J Asthma. 2022 Feb;59(2):239-242. doi: 10.1080/02770903.2020.1861622. Epub 2020 Dec 16.

引用本文的文献

1
Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study.奈玛特韦/利托那韦与莫努匹韦在哮喘患者中的短期和长期比较疗效：一项队列研究
Respir Res. 2025 Feb 28;26(1):75. doi: 10.1186/s12931-025-03156-2.
2
Post-COVID-19 Symptoms in Adults with Asthma-Systematic Review.哮喘成年患者的新冠后症状——系统评价
Biomedicines. 2023 Aug 14;11(8):2268. doi: 10.3390/biomedicines11082268.
3
Post-Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records-Based Study.哮喘患者 COVID-19 后呼吸道症状：一项基于电子健康记录的研究。
J Allergy Clin Immunol Pract. 2023 Mar;11(3):825-835.e3. doi: 10.1016/j.jaip.2022.12.003. Epub 2022 Dec 22.
4
Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism.长新冠及其潜在病理生理机制的证据图谱和综述。
Infection. 2022 Oct;50(5):1053-1066. doi: 10.1007/s15010-022-01835-6. Epub 2022 Apr 30.
5
Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study.女性性别是与新冠后长期相关症状相关的风险因素，但与新冠病毒病症状无关：LONG-COVID-EXP-CM多中心研究
J Clin Med. 2022 Jan 14;11(2):413. doi: 10.3390/jcm11020413.
6
Genetic variation of allergic disease is associated with the susceptibility to COVID-19.过敏性疾病的基因变异与对新冠病毒的易感性有关。
J Infect. 2022 May;84(5):e92-e93. doi: 10.1016/j.jinf.2022.01.015. Epub 2022 Jan 14.
7
Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.哮喘患者中新冠后长期症状的患病率相似：一项病例对照研究。
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.04.034. Epub 2021 May 3.

本文引用的文献

1
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.在一个国际队列中对长期新冠进行特征描述：7个月的症状及其影响。
EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15.
2
Sequelae in Adults at 6 Months After COVID-19 Infection.COVID-19 感染 6 个月后成年人的后遗症。
JAMA Netw Open. 2021 Feb 1;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830.
3
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study.新冠病毒感染后综合征。发生率和危险因素：一项地中海队列研究。
J Infect. 2021 Mar;82(3):378-383. doi: 10.1016/j.jinf.2021.01.004. Epub 2021 Jan 12.
4
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort.COVID-19 住院患者的预后及其随访意义：来自英国前瞻性队列研究的结果。
Thorax. 2021 Apr;76(4):399-401. doi: 10.1136/thoraxjnl-2020-216086. Epub 2020 Dec 3.
5
COVID-19 Susceptibility in Bronchial Asthma.COVID-19 易感性与支气管哮喘。
J Allergy Clin Immunol Pract. 2021 Feb;9(2):684-692.e1. doi: 10.1016/j.jaip.2020.11.020. Epub 2020 Nov 24.
6
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.吸入性类固醇 Ciclesonide 通过靶向细胞培养中的病毒复制转录复合物来阻断 SARS-CoV-2 RNA 复制。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01648-20.
7
The "post-COVID" syndrome: How deep is the damage?“新冠后”综合征：损害有多严重？
J Med Virol. 2021 Feb;93(2):673-674. doi: 10.1002/jmv.26465. Epub 2020 Sep 29.
8
Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation.COVID-19 感染幸存者出院后的症状和康复需求：一项横断面评估。
J Med Virol. 2021 Feb;93(2):1013-1022. doi: 10.1002/jmv.26368. Epub 2020 Aug 17.
9
Asthma and COPD in Hospitalized COVID-19 Patients.住院COVID-19患者中的哮喘和慢性阻塞性肺疾病
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.